Segment Data

9 Months Ended

Jun. 30, 2011

Segment Data [Abstract]

Segment Data

Note 6 — Segment Data

The Company’s organizational structure is based upon its three principal business segments: BD Medical (“Medical”), BD Diagnostics (“Diagnostics”), and BD Biosciences (“Biosciences”). The Company evaluates segment performance based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses. From time to time, the Company hedges against certain forecasted sales of U.S.-produced products sold outside the United States. Gains and losses associated with these foreign currency translation hedges are reported in segment revenues based upon their proportionate share of these international sales of U.S.-produced products. Financial information for the Company’s segments was as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Revenues (A)
Medical	$	1,044,836		$	945,522		$	2,952,713		$	2,837,827
Diagnostics		631,359			576,269			1,838,429			1,727,415
Biosciences		337,886			309,120			986,967			933,896
	$	2,014,081		$	1,830,911		$	5,778,109		$	5,499,138
Segment Operating Income
Medical	$	324,170		$	273,186		$	887,080		$	839,436
Diagnostics		164,293			146,703			481,322			452,789
Biosciences		89,943			87,101			275,643			269,797
Total Segment Operating Income		578,406			506,990			1,644,045			1,562,022
Unallocated Items (B)		(117,765	)		(93,617	)		(346,792	)		(314,980	)
Income from Continuing Operations Before Income Taxes	$	460,641		$	413,373		$	1,297,253		$	1,247,042

(A)	Intersegment revenues are not material.
(B)	Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Revenues by Organizational Units
BD Medical
Medical Surgical Systems	$	529,018	$	493,553	$	1,546,334	$	1,507,995
Diabetes Care		220,184		197,152		641,826		586,658
Pharmaceutical Systems		295,634		254,817		764,553		743,174
	$	1,044,836	$	945,522	$	2,952,713	$	2,837,827
BD Diagnostics
Preanalytical Systems	$	330,326	$	303,526	$	949,194	$	891,362
Diagnostic Systems		301,033		272,743		889,235		836,053
	$	631,359	$	576,269	$	1,838,429	$	1,727,415
BD Biosciences
Cell Analysis	$	255,028	$	230,433	$	751,287	$	704,243
Discovery Labware		82,858		78,687		235,680		229,653
	$	337,886	$	309,120	$	986,967	$	933,896
	$	2,014,081	$	1,830,911	$	5,778,109	$	5,499,138

Revenues by geographic areas were as follows:

	Three Months Ended				Nine Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Total Revenues
United States	$	855,464	$	809,428	$	2,513,247	$	2,454,604
International		1,158,617		1,021,483		3,264,862		3,044,534
	$	2,014,081	$	1,830,911	$	5,778,109	$	5,499,138